Iterum Therapeutics plc (NASDAQ:ITRM) has seen 19.71 million shares traded in the last trading session. The company, currently valued at $349.44M, closed the last trade
During the last session, Iterum Therapeutics plc (NASDAQ:ITRM)’s traded shares were 5.91 million. At the end of the trading day, the stock’s price was $1.78,
In the last trading session, 9,559,846 shares of the Iterum Therapeutics plc(NASDAQ:ITRM) were traded, and its beta was 0. Most recently the company’s share price
Iterum Therapeutics plc (NASDAQ:ITRM)’s traded shares stood at 8,388,986 during the last session, with the company’s beta value hitting 0. At the close of trading,
In the last trading session, 66,058,348 Iterum Therapeutics plc (NASDAQ:ITRM) shares changed hands as the company’s beta touched 0. With the company’s per share price
In last trading session, Iterum Therapeutics plc (NASDAQ:ITRM) saw 7,390,974 shares changing hands with its beta currently measuring 0. Company’s recent per share price level
Iterum Therapeutics plc (NASDAQ:ITRM) has a beta value of 0 and has seen 5,587,769 shares traded in the last trading session. The company, currently valued
During the last session, Iterum Therapeutics plc (NASDAQ:ITRM)’s traded shares were 5,676,656, with the beta value of the company hitting 0. At the end of
In the last trading session, 7,404,195 shares of the Iterum Therapeutics plc(NASDAQ:ITRM) were traded, and its beta was 0. Most recently the company’s share price
In the latest trading session, 3,476,091 Iterum Therapeutics plc (NASDAQ:ITRM) shares changed hands as the company’s beta touched 0. With the company’s most recent per